Enrollment of phase 3 trial of RPC1063 in RRMS begins
Enrollment of phase 3 trial of RPC1063 in RRMS begins
Receptos, Inc. announced today that the Company has enrolled the first patients in the Phase 3 portion of RADIANCE, its Phase 2/3 study of RPC1063 in relapsing multiple sclerosis (RMS). The announcement follows the review of interim analysis of the Phase 2 portion of the study which was announced in December 2013....... Read More - http://www.ms-uk.org/RPC1063
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1455 Views
-
Last post by NHE
-
- 0 Replies
- 2171 Views
-
Last post by NHE
-
- 0 Replies
- 2031 Views
-
Last post by NHE
-
- 0 Replies
- 10626 Views
-
Last post by NHE
-
- 0 Replies
- 1102 Views
-
Last post by frodo
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 2 Replies
- 3849 Views
-
Last post by DIM
-
- 0 Replies
- 2191 Views
-
Last post by NHE
-
- 0 Replies
- 10246 Views
-
Last post by NHE